Definitive Radiation Therapy for Early Glottic Cancer: Experience of Two Fractionation Schedules
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives. The authors would report the results of definitive radiation therapy (RT) for early glottic cancer by two different radiation dose schedules. Methods. From February of 1995 till June of 2008, 157 patients with T1-2N0 glottic cancer were treated with curative RT at Samsung Medical Center. All patients had squamous cell carcinoma, and there were 89 patients (56.7%) with T1a,36 (22.9%) with T1b, and 32 (20.4%) with T2. Two different radiation dose schedules were used: 70 Gy in 35 fractions to 64 patients (40.8%, group A); and 67.5 Gy in 30 fractions to 93 patients (59.2%, group B). The median treatment durations were 50 days (range, 44 to 59 days) and 44 days (range, 40 to 67 days) in the groups A and B, respectively. Results. The median follow-up durations were 85 and 45 months for the groups A and B. No severe late complication of RTOG grade 3 or higher was observed, and there was no difference in acute or chronic complication between the groups. Twenty-four patients experienced treatment failure: local recurrence only in 19 patients; regional recurrence only in one; combined local and regional recurrence in four; and systemic metastasis in none. The overall 5-year disease-free survival and disease-specific survival rates were 84.7% and 94.8%. The disease-free survival rate in the group B was better (78.3% vs. 90.8%, P=0.031). This difference was significant only in T1 stage (83.4% vs. 94.6%, P=0.025), but not in T2 (62.7% vs. 60.6%, P=0.965). Univariate analysis showed that the tumor extent, cord mobility,T-stage, and the dose schedule had significant influence on the disease-free survival, and multivariate analysis showed that only the tumor extent and the dose schedule were associated with the disease-free survival. Conclusion. Superior disease-free survival could be achieved by 2.25 Gy per fraction without increased toxicity over shorter RT duration, when compared with 2.0 Gy per fraction.
Abstract
Objectives. The authors would report the results of definitive radiation therapy (RT) for early glottic cancer by two different radiation dose schedules. Methods. From February of 1995 till June of 2008, 157 patients with T1-2N0 glottic cancer were treated with curative RT at Samsung Medical Center. All patients had squamous cell carcinoma, and there were 89 patients (56.7%) with T1a,36 (22.9%) with T1b, and 32 (20.4%) with T2. Two different radiation dose schedules were used: 70 Gy in 35 fractions to 64 patients (40.8%, group A); and 67.5 Gy in 30 fractions to 93 patients (59.2%, group B). The median treatment durations were 50 days (range, 44 to 59 days) and 44 days (range, 40 to 67 days) in the groups A and B, respectively. Results. The median follow-up durations were 85 and 45 months for the groups A and B. No severe late complication of RTOG grade 3 or higher was observed, and there was no difference in acute or chronic complication between the groups. Twenty-four patients experienced treatment failure: local recurrence only in 19 patients; regional recurrence only in one; combined local and regional recurrence in four; and systemic metastasis in none. The overall 5-year disease-free survival and disease-specific survival rates were 84.7% and 94.8%. The disease-free survival rate in the group B was better (78.3% vs. 90.8%, P=0.031). This difference was significant only in T1 stage (83.4% vs. 94.6%, P=0.025), but not in T2 (62.7% vs. 60.6%, P=0.965). Univariate analysis showed that the tumor extent, cord mobility,T-stage, and the dose schedule had significant influence on the disease-free survival, and multivariate analysis showed that only the tumor extent and the dose schedule were associated with the disease-free survival. Conclusion. Superior disease-free survival could be achieved by 2.25 Gy per fraction without increased toxicity over shorter RT duration, when compared with 2.0 Gy per fraction.
참고문헌 (30)
- DeVita VT, "DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8th ed" (2008), Lippincott Williams & Wilkins
- Akimoto T, "Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control", Int J Radiat Oncol Biol Phys, 64(4), pp.995~1001 (2006)
- 김원택, "조기 성문암 환자에서의 방사선치료", Radiation oncology journal, 20(4), pp.295~302 (2002), 대한방사선종양학회
- Lee HS, "The heterogeneity of T2NO glottic carcinoma treated by irradiation", J Korean Soc Ther Radiol, 8(2), pp.199~206 (1990)
- Mendenhall WM, "Management of T1-T2 glottic carcinomas", Cancer, 100(9), pp.1786~1792 (2004)
- Yamazaki H, "Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time", Int J Radiat Oncol Biol Phys, 64(1), pp.77~82 (2006)
- Garden AS, "Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice-daily treatment?", Int J Radiat Oncol Biol Phys, 55(2), pp.322~328 (2003)
- McCoul ED, "Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma", Arch Otolaryngol Head Neck Surg, 135(5), pp.479~486 (2009)
- 박지훈, "초기 성문암에서 레이저 성대절제술과 방사선치료 결과", 대한이비인후과학회지 두경부외과학, 45(2), pp.159~163 (2002), 대한이비인후과학회
- Dey P, "Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer", Cochrane Database Syst Rev, 2 (2002)
- Agrawal N, "Management of early-stage laryngeal cancer", Otolaryngol Clin North Am, 41(4), pp.757~769 (2008)
- Marshak G, "Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients", Int J Radiat Oncol Biol Phys, 43(5), pp.1009~1013 (1999)
- Nozaki M, "Radiation therapy for T1 glottic cancer: involvement of the anterior commissure", Anticancer Res, 20(2), pp.1121~1124 (2000)
- Wolfensberger M, "Endoscopic laser surgery for early glottic carcinoma: a clinical and experimental study", Laryngoscope, 100(10), pp.1100~1105 (1990)
- Fowler JF, "Fractionated radiation therapy after Strandqvist", Acta Radiol Oncol, 23(4), pp.209~16 (1984)
- Horiot JC, "Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial", Radiother Oncol, 44(2), pp.111~121 (1997)
- Harwood AR, "Radiotherapy of early glottic cancer-II", Int J Radiat Oncol Biol Phys, 5(4), pp.477~482 (1979)
- Randall ME, "T1-T2 carcinoma of the glottis: relative hypofractionation", Radiology, 179(2), pp.569~571 (1991)
- van der Voet JC, "The impact of treatment time and smoking on local control and complications in T1 glottic cancer", Int J Radiat Oncol Biol Phys, 42(2), pp.247~255 (1998)
- Fein DA, "Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?", Int J Radiat Oncol Biol Phys, 34(4), pp.823~831 (1996)
- Le QT, "Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma", Int J Radiat Oncol Biol Phys, 39(1), pp.115~126 (1997)
- Sakata K, "Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma: consideration of time-dose factors", Strahlenther Onkol, 184(7), pp.364~369 (2008)
- Yu E, "Impact of radiation therapy fraction size on local control of early glottic carcinoma", Int J Radiat Oncol Biol Phys, 37(3), pp.587~591 (1997)
- Rudoltz MS, "Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis", Int J Radiat Oncol Biol Phys, 26(5), pp.767~772 (1993)
- Kim YH, "Radiotherapy of early stage glottic cancer", J Korean Soc Ther Radiol, 15(4), pp.315~320 (1997)
- Mendenhall WM, "T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy", J Clin Oncol, 19(20), pp.4029~4036 (2001)
- Nibu K, "Partial laryngectomy in the treatment of radiation-failure of early glottic carcinoma", Head Neck, 19(2), pp.116~120 (1997)
- Fujita M, "Second malignant neoplasia in patients with T1 glottic cancer treated with radiation", Laryngoscope, 108(12), pp.1853~1855 (1998)
- Narayana A, "Second primary tumors in laryngeal cancer: results of long-term follow-up", Int J Radiat Oncol Biol Phys, 42(3), pp.557~562 (1998)
- Franchin G, "Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients", Cancer, 98(4), pp.765~772 (2003)